By comparison, the use of chemotherapy was strongly predictive of outcome with no single regimen performing better than any other (carboplatin vs. cisplatin-based) and all regimens producing superior results compared to no chemotherapy at all (p<0.001). This is corroborated by a recent MaGIC report demonstrating equipoise in contemporaneous trials using cisplatin and carboplatin-based regimens in paediatric germ cell tumours (13).